AMPKα1 can be SUMOylated, and its SUMOylation inhibits the response of AMPK towards mTORC1 signaling, suggesting that suppression of AMPKα1 SUMOylation can be applied to regulate AMPK activation and thus suppress breast cancer cell growth (39). Here, PRKAA1 is linked to breast carcinoma.